Li Ping, Li Juan, Chen Tengfei, Wang Huaqi, Chu Heying, Chang Jingxia, Zang Wenqiao, Wang Yuanyuan, Ma Yunyun, Du Yuwen, Zhao Guoqiang, Zhang Guojun
Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
Department of Microbiology and Immunology, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
Int J Mol Med. 2014 Jun;33(6):1554-62. doi: 10.3892/ijmm.2014.1712. Epub 2014 Mar 24.
Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology with considerable morbidity and mortality. Seeking informative diagnostic markers with greater clinical significance is essential for the early diagnosis of IPF. microRNAs (miRNAs or miRs) have emerged as novel serum diagnostic biomarkers for various diseases. In this study, we performed microarray analysis of the miRNA expression profile in the serum of patients with IPF compared to that of control subjects. We then performed a preliminary analysis of biological functions for the most differentially expressed miRNAs. Some of the microarray results were validated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The results from this study provide evidence to link the biological role of miRNAs to IPF, and suggest that miRNAs may undertake a variety of functions. Additionally, we found that the altered expression levels of miR-21, miR-155 and miR-101-3p were associated with forced vital capacity (FVC) and radiological features in IPF. Our data may serve as a basis for further investigation, preferably in large prospective studies, before miRNA can be used as a non-invasive screening tool for IPF in routine clinical practice.
特发性肺纤维化(IPF)是一种病因不明的疾病,具有较高的发病率和死亡率。寻找具有更大临床意义的信息性诊断标志物对于IPF的早期诊断至关重要。微小RNA(miRNA或miR)已成为各种疾病的新型血清诊断生物标志物。在本研究中,我们对IPF患者血清中的miRNA表达谱与对照受试者进行了微阵列分析。然后,我们对差异表达最明显的miRNA进行了生物学功能的初步分析。部分微阵列结果通过定量逆转录-聚合酶链反应(qRT-PCR)进行了验证。本研究结果为将miRNA的生物学作用与IPF联系起来提供了证据,并表明miRNA可能具有多种功能。此外,我们发现miR-21、miR-155和miR-101-3p表达水平的改变与IPF患者的用力肺活量(FVC)和影像学特征相关。在miRNA能够作为IPF的非侵入性筛查工具用于常规临床实践之前,我们的数据可为进一步研究提供基础,最好是开展大型前瞻性研究。